The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Chronic kidney disease (CKD) affects millions globally, causing significant morbidity and mortality.
• CKD is often linked with diabetes mellitus, hypertension, and existing cardiovascular diseases, creating a complex health challenge.
• Patients with CKD, especially those on dialysis, face a heightened risk of cardiovascular complications.

Purpose of the Study:

• To review the epidemiology of CKD.
• To explore cardiovascular complications associated with CKD.
• To discuss current and emerging management strategies for CKD, focusing on cardiovascular disease prevention and early intervention.

Main Methods:

• Literature review of epidemiological data, clinical studies, and therapeutic guidelines.
• Analysis of the impact of comorbidities like diabetes and hypertension on CKD progression.
• Evaluation of pharmacological interventions, including ACE inhibitors, ARBs, and SGLT2 inhibitors, and lifestyle modifications.

Main Results:

• CKD is driven by diabetes, hypertension, and cardiovascular diseases, necessitating a multifaceted management approach.
• Dietary modifications (sodium, phosphorus, potassium restriction) and medications (ACE inhibitors, ARBs, SGLT2 inhibitors) are crucial for preserving renal function and improving outcomes.
• Comprehensive strategies are required to manage the increased cardiovascular risk in dialysis patients.

Conclusions:

• Early intervention and preventive measures are critical to mitigate the global burden of CKD.
• A coordinated approach involving lifestyle changes, pharmacological treatments, and regular monitoring is essential for managing CKD and its cardiovascular sequelae.
• Ongoing research into novel therapies and personalized medicine is vital for advancing CKD care and improving patient quality of life.